ID
CLVS

Integral Derivatives’s Clovis Oncology, Inc. CLVS Stock Holding History

Integral Derivatives’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-8,200
Closed -$558K – 1093
2017
Q4 		$558K Sell
8,200
-3,500
-30% -$245K 0.01% 681
2017
Q3 		$964K Buy
+11,700
New +$928K 0.02% 508
2016
Q2 		– Sell
-11,000
Closed -$211K – 1129
2016
Q1 		$211K Buy
+11,000
New +$233K 0.01% 739
2014
Q2 		– Sell
-8,700
Closed -$603K – 1560
2014
Q1 		$603K Buy
+8,700
New +$639K 0.01% 829

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return